Boston Scientific hit by cyberattack, disrupting global operations

Medical device manufacturer Boston Scientific announced Wednesday that a cyberattack has disrupted its global operations, impacting critical systems responsible for processing and shipping customer orders. The company is currently working to restore affected functions, but the full extent and timeline of the recovery remain uncertain.

The incident was uncovered on Tuesday, and Boston Scientific has since engaged external cybersecurity experts to investigate the breach and mitigate the ongoing threat. In a securities filing, the company stated that the attack has caused, and is expected to continue causing, significant disruptions and limitations to its information systems and business applications.

“

The incident has caused, and is expected to continue to cause, disruptions and limitations of access to certain of the Company's information systems and business applications that support aspects of the Company's operations, including the ability to process and ship customer orders.

Boston Scientific's shares experienced a decline of up to 6% in early trading following the announcement. The healthcare sector has become a prime target for cybercriminals, with research indicating it accounted for 22% of disclosed attacks in 2025. Boston Scientific produces a wide range of medical technologies, including devices for cardiac care, cancer treatment, and gastrointestinal diagnostics.

The company is diligently working towards a full restoration of its systems. However, without a clear timeline for resolution, the ongoing disruption poses a challenge to its business operations and customer fulfillment processes.

“

While the Company is working diligently to restore affected functions and systems access, the timeline for a full restoration is not yet known.